XIAP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.880200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.601600E-01
Normal-vs-Stage2
9.975400E-01
Normal-vs-Stage3
8.884400E-02
Normal-vs-Stage4
4.255400E-01
Stage1-vs-Stage2
3.564400E-01
Stage1-vs-Stage3
8.575700E-03
Stage1-vs-Stage4
6.662800E-01
Stage2-vs-Stage3
1.062000E-01
Stage2-vs-Stage4
2.270000E-01
Stage3-vs-Stage4
5.795800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.711800E-01
Normal-vs-AfricanAmerican
5.805400E-01
Normal-vs-Asian
9.266200E-01
Caucasian-vs-AfricanAmerican
2.593800E-01
Caucasian-vs-Asian
8.904400E-01
AfricanAmerican-vs-Asian
4.790600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.842400E-01
Normal-vs-Female
9.820800E-01
Male-vs-Female
9.886600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.466800E-01
Normal-vs-Age(41-60Yrs)
5.862000E-01
Normal-vs-Age(61-80Yrs)
7.874600E-01
Normal-vs-Age(81-100Yrs)
7.516400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.138800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.426600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.008600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.123400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.253190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.416800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.596600E-01
Normal-vs-Daily Drinker
7.192800E-01
Normal-vs-Weekly Drinker
7.142400E-01
Normal-vs-Occasional Drinker
5.218400E-01
Normal-vs-Social Drinker
8.316200E-01
Non Drinker-vs-Daily Drinker
8.782800E-01
Non Drinker-vs-Weekly Drinker
8.961800E-01
Non Drinker-vs-Occasional Drinker
7.015800E-02
Non Drinker-vs-Social Drinker
3.287600E-01
Daily Drinker-vs-Weekly Drinker
9.961000E-01
Daily Drinker-vs-Occasional Drinker
7.142200E-02
Daily Drinker-vs-Social Drinker
3.080600E-01
Weekly Drinker-vs-Occasional Drinker
9.570200E-02
Weekly Drinker-vs-Social Drinker
3.522400E-01
Occasional Drinker-vs-Social Drinker
5.352600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.127500E-02
Normal-vs-Grade 2
2.128100E-02
Normal-vs-Grade 3
2.248000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.433400E-01
Grade 1-vs-Grade 3
6.644600E-01
Grade 1-vs-Grade 4
9.127500E-02
Grade 2-vs-Grade 3
4.514800E-01
Grade 2-vs-Grade 4
2.128100E-02
Grade 3-vs-Grade 4
2.248000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.084000E-01
Normal-vs-NonDiabetic
9.783800E-01
Diabetic-vs-NonDiabetic
6.640400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.174800E-01
Normal-vs-NoPancreatitis
9.046600E-01
Pancreatitis-vs-NoPancreatitis
5.137200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.938600E-01
Normal-vs-N1
9.807000E-01
N0-vs-N1
9.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.849000E-01
Normal-vs-TP53-NonMutant
7.685000E-01
TP53-Mutant-vs-TP53-NonMutant
3.910400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
